Sulfur mustard research--strategies for the development of improved medical therapy.
about
Silibinin attenuates sulfur mustard analog-induced skin injury by targeting multiple pathways connecting oxidative stress and inflammationClinically-relevant cutaneous lesions by nitrogen mustard: useful biomarkers of vesicants skin injury in SKH-1 hairless and C57BL/6 miceSulfur mustard analog induces oxidative stress and activates signaling cascades in the skin of SKH-1 hairless mice.Biological and molecular mechanisms of sulfur mustard analogue-induced toxicity in JB6 and HaCaT cells: possible role of ataxia telangiectasia-mutated/ataxia telangiectasia-Rad3-related cell cycle checkpoint pathwayActivation of DNA damage repair pathways in response to nitrogen mustard-induced DNA damage and toxicity in skin keratinocytes.Doxycycline hydrogels with reversible disulfide crosslinks for dermal wound healing of mustard injuriesAirway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation.Efficacy of glutathione in ameliorating sulfur mustard analog-induced toxicity in cultured skin epidermal cells and in SKH-1 mouse skin in vivo.Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity.Prevention and treatment of respiratory consequences induced by sulfur mustard in Iranian casualties.2-Chloroethyl ethyl sulfide causes microvesication and inflammation-related histopathological changes in male hairless mouse skin.Topical nitrogen mustard exposure causes systemic toxic effects in mice.Inhalation exposure systems for the development of rodent models of sulfur mustard-induced pulmonary injurySulfur mustard analog, 2-chloroethyl ethyl sulfide-induced skin injury involves DNA damage and induction of inflammatory mediators, in part via oxidative stress, in SKH-1 hairless mouse skin.Comparative proteomic study reveals the molecular aspects of delayed ocular symptoms induced by sulfur mustardNitrogen mustard exposure of murine skin induces DNA damage, oxidative stress and activation of MAPK/Akt-AP1 pathway leading to induction of inflammatory and proteolytic mediators.Impact of psychological problems in chemical warfare survivors with severe ophthalmologic complication, a cross sectional studyRole of TNFR1 in lung injury and altered lung function induced by the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide.A review on delayed toxic effects of sulfur mustard in Iranian veteransMustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure.Inflammatory biomarkers of sulfur mustard analog 2-chloroethyl ethyl sulfide-induced skin injury in SKH-1 hairless mice.Absence of a p53 allele delays nitrogen mustard-induced early apoptosis and inflammation of murine skinSulfur mustard induced mast cell degranulation in mouse skin is inhibited by a novel anti-inflammatory and anticholinergic bifunctional prodrug.Phosgene oxime: Injury and associated mechanisms compared to vesicating agents sulfur mustard and lewisite.Histopathological and Molecular Changes in the Rabbit Cornea From Arsenical Vesicant Lewisite Exposure.Long-term complications of sulfur mustard poisoning: retinal electrophysiological assessment in 40 severely intoxicated Iranian veterans.TRPA1 and CGRP antagonists counteract vesicant-induced skin injury and inflammation.Delayed Complications and Long-term Management of Sulfur Mustard Poisoning: Recent Advances by Iranian Researchers (Part I of II).
P2860
Q28484076-61E1D1BF-C77B-4C61-A894-48DA79B9DA4CQ28534205-75DD3A46-71FD-4BF6-8A41-9A149D8A9205Q33570853-79754D58-0F33-49A4-80BE-9784DF20D371Q33578169-E5C7683E-D287-477B-9347-389F96F06C5DQ34353620-52EB83BF-802E-4F91-866A-85DBFC4A7506Q34369959-70676B16-74B2-4947-89E7-5DED1B39BD3BQ34535026-FB5FC1D0-8179-4170-AD02-BB24D878FF06Q34552069-50F76999-EA3F-4FDD-9BC7-D9202FA4CA99Q34554830-4BCABE04-F0CB-4F22-979E-E346840BB680Q34721389-F7A8A1CF-3490-4F2A-A514-0741130B4E50Q34902510-D15F09E3-A2CE-4F23-922F-243D048B07B9Q35019537-147FD5C0-F6E6-4CA1-A8BD-738C84BC0E95Q35160155-7625CBEA-7008-438F-8953-BBFCFAE6AC9EQ35516441-ED85B089-A214-40C9-9E57-AF396F0633A7Q35562012-EA0906F2-9F85-468A-AE5D-8BD347F7FEB9Q35602730-0BAFA328-C10E-46A3-B854-D13E760686A9Q35980246-3617BF83-9B87-4809-8BE1-EC9109C0394AQ36461931-A7677D81-FCC5-499D-AEC9-AC4984C994CAQ36564918-2FC0CED2-AA5F-421D-A331-F98A7437C420Q37083553-0E8D892E-7F8A-4BD3-918F-CFC358BB6A6FQ37101564-CAD771C7-E429-4112-9752-3C1DE1ED948CQ37254678-ECCC8904-8173-428B-A414-308AF8BE9F8AQ47615630-967EC55A-D8AD-4E6E-BA66-9A37B3F0A155Q47710852-D4B9802E-9B7F-450B-8929-488ADCF51654Q49651449-4E028283-BB6E-4313-8317-2AE92993603FQ50848254-AAD423C4-D006-43B4-A24C-DAFF4345BADAQ52657444-14AFE549-942C-46BC-83FE-C842953C2540Q55021435-CE149B05-8057-4BFF-8578-A36103DB8167
P2860
Sulfur mustard research--strategies for the development of improved medical therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sulfur mustard research--strategies for the development of improved medical therapy.
@en
Sulfur mustard research--strategies for the development of improved medical therapy.
@nl
type
label
Sulfur mustard research--strategies for the development of improved medical therapy.
@en
Sulfur mustard research--strategies for the development of improved medical therapy.
@nl
prefLabel
Sulfur mustard research--strategies for the development of improved medical therapy.
@en
Sulfur mustard research--strategies for the development of improved medical therapy.
@nl
P2093
P2860
P1433
P1476
Sulfur mustard research--strategies for the development of improved medical therapy
@en
P2093
Frank Balszuweit
Helmut Kreppel
Horst Thiermann
Judith Emmler
Marianne Jochum
P2860
P577
2008-06-10T00:00:00Z